
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.05 | 2.85714285714 | 1.75 | 1.91 | 1.74 | 134174 | 1.82249896 | CS |
4 | -0.05 | -2.7027027027 | 1.85 | 1.985 | 1.67 | 162168 | 1.81132282 | CS |
12 | -0.14 | -7.21649484536 | 1.94 | 2.15 | 1.67 | 223877 | 1.91640313 | CS |
26 | 0.07 | 4.04624277457 | 1.73 | 2.15 | 1.67 | 203606 | 1.89623235 | CS |
52 | -16.54 | -90.185387132 | 18.34 | 18.54 | 1.55 | 425440 | 3.31419989 | CS |
156 | -16.96 | -90.4051172708 | 18.76 | 24.42 | 1.55 | 214158 | 6.95633096 | CS |
260 | -16.96 | -90.4051172708 | 18.76 | 24.42 | 1.55 | 214158 | 6.95633096 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions